These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 19867388)
1. Mixed lymphocyte reactivity against normal cells by splenic lymphocytes from tumor-bearing mice : ii. Studies of autoimmune-like activity in completely syngeneic and semisyngeneic systems. Devlin RG; McCurdy JD; Baronowsky PE J Exp Med; 1974 Jan; 139(1):230-7. PubMed ID: 19867388 [TBL] [Abstract][Full Text] [Related]
2. Mixed lymphocyte reactivity against normal cells by splenic lymphocytes from tumor-bearing mice : I. Studies of vigorous immune responsiveness induced in f(1) mice by parental strain tumor cells. Devlin RG; McCurdy JD; Baronowsky PE J Exp Med; 1974 Jan; 139(1):224-9. PubMed ID: 19867387 [TBL] [Abstract][Full Text] [Related]
3. Immune response-associated antigens on mouse leukemia cells. II. Anti-Ia sera inhibit the MLR reaction between normal GR spleen cells and syngeneic spleen cells of GRSL tumor-bearing mice. Okuda K; Neely BC; Hilgers J; David CS Transplantation; 1978 Nov; 26(5):300-3. PubMed ID: 151953 [TBL] [Abstract][Full Text] [Related]
4. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors. Fortner GW; Kripke ML J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296 [TBL] [Abstract][Full Text] [Related]
5. Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules. Glimcher LH; Longo DL; Green I; Schwartz RH J Exp Med; 1981 Nov; 154(5):1652-70. PubMed ID: 6170721 [TBL] [Abstract][Full Text] [Related]
6. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells. Gillis S; Smith KA J Exp Med; 1977 Aug; 146(2):468-82. PubMed ID: 69003 [TBL] [Abstract][Full Text] [Related]
7. Production of IL2 and IL3 in syngeneic mixed lymphocyte reactions of BALB/c mice are elevated during a period of moderate dietary protein deficiency. Petro TM; Schwartz KM; Chen SS Immunol Invest; 1994 Mar; 23(2):143-52. PubMed ID: 8194854 [TBL] [Abstract][Full Text] [Related]
8. Genetic control of in vitro NK-activity and in vivo resistance to tumors. Kärre K; Klein GO; Kiessling R; Klein G Tokai J Exp Clin Med; 1983 Dec; 8(5-6):429-48. PubMed ID: 6681339 [TBL] [Abstract][Full Text] [Related]
10. Altered immune response patterns in murine syngeneic pregnancy: presence of natural null suppressor cells in maternal spleen identifiable by monoclonal antibodies. Hoskin DW; Gronvik KO; Hooper DC; Reilly BD; Murgita RA Cell Immunol; 1989 Apr; 120(1):42-60. PubMed ID: 2522830 [TBL] [Abstract][Full Text] [Related]
11. A syngeneic MLR induced in vivo results in T-cell mediated immune suppression. van Vollenhoven RF; Braver JK; Francus T; Schwartz RL; Thorbecke GJ; Siskind GW Cell Immunol; 1987 May; 106(2):397-407. PubMed ID: 2952287 [TBL] [Abstract][Full Text] [Related]
12. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells. Plata F; Jongeneel V; Cerottini JC; Brunner KT Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429 [TBL] [Abstract][Full Text] [Related]
13. Kinetics of the reactivity of subpopulations of spleen cells of mice bearing virus-induced mammary tumors to syngeneic antigenic extracts in vitro. Supportive and suppressive effects of macrophages. Laing CA Cancer Immunol Immunother; 1982; 13(2):98-104. PubMed ID: 6297714 [TBL] [Abstract][Full Text] [Related]
14. The differentiation of T lymphocytes. Density characterisation of thymic and peripheral T cells responding in syngeneic and allogenic mixed lymphocyte reactions. von Boehmer H; Shortman K Aust J Exp Biol Med Sci; 1975 Aug; 53(4):281-95. PubMed ID: 132923 [TBL] [Abstract][Full Text] [Related]
15. Tumor-specific immune responsiveness of the tumor-bearing host. Burk MW; Yu S; McKhann CF Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694 [TBL] [Abstract][Full Text] [Related]
16. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors. Fuyama S; Komatsu H; Arai S Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379 [TBL] [Abstract][Full Text] [Related]
17. Studies on the syngeneic mixed lymphocyte reaction. II. Decline in he syngeneic mixed lymphocyte reaction with age. Gutowski JK; Weksler ME Immunology; 1982 Aug; 46(4):801-8. PubMed ID: 6213555 [TBL] [Abstract][Full Text] [Related]
18. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation. Treves AJ; Cohen IR; Feldman M Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880 [TBL] [Abstract][Full Text] [Related]
19. Induction by an immunogenic immunomodulating agent of nonspecific T cell suppression of lymphocyte responsiveness in MLR but not of antibody production. Reuben C; Halperin D; Ben-Efraim S; Weiss DW Cancer Immunol Immunother; 1988; 26(2):153-60. PubMed ID: 2965973 [TBL] [Abstract][Full Text] [Related]
20. Role of B cells in the stimulation of syngeneic mixed lymphocyte responses. Thorbecke GJ; Chapman-Alexander J; Katz IR; Bienenstock A; Asofsky R Behring Inst Mitt; 1983 May; (72):107-16. PubMed ID: 6242330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]